Hormone replacement therapy

Medicine

Volumn 35, Issue 9, 2007, Pages 529-532

  Gebbie, Ailsa ^a  

^a NHS LOTHIAN   (United Kingdom)

Author keywords

breast cancer; coronary heart disease; HRT; vasomotor symptoms; venous thromboembolism

Indexed keywords

ESTROGEN; PLACEBO; PREGNANE DERIVATIVE; PROGESTERONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE;

AGE DISTRIBUTION; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COLORECTAL CANCER; CORONARY RISK; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSAL SYNDROME; META ANALYSIS; OVARY CANCER; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SHORT SURVEY; SYSTEMATIC REVIEW; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; WELLBEING;

EID: 34548174755     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2007.07.002     Document Type: Short Survey

References (18)

1. Boseley S. The truth about HRT. The Guardian. (6th June 2007)
2. MacLennan A., Lester S., and Moore V. Oral oestrogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 18 4 (October 2004) CD002978
3. Barrett Conner E., Mosca L., Collins P., et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 355 (2006) 125-137
4. Sestak I., Kealy R., Edwards R., Forbes J., and Cuzick J. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms. J Clin Oncol 24 (2006) 3991-3996
5. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2003 Incidence and Mortality Web-based Report (2007.), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta. Available at: www.cdc.gov/uscs
6. Writing Group for the Womens' Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
7. Anderson G., Limacher M., Assaf A., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 (2004) 1701-1712
8. Million Women Steering Committee. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 362 (2003) 419-427
9. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative re-analysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350 (1997) 1047-1059
10. Stefanik M. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 295 (2006) 1647-1657
11. Danforth K., Tworoger S., Hecht J., Rosner B., Colditz G., and Hankinson S. A prospective study of postmenopausal hormones and ovarian cancer risk. Br J Cancer 96 (2007) 151-156
12. Million Women Study Collaborators. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 369 (2007) 1131-1137
13. La Vecchia C., Gallus S., and Fernandez E. Hormone replacement therapy and colorectal cancer: an update. J Br Menopause Soce 11 (2005) 166-172
14. Canonico M., Oger E., Plu-Bureau G., et al. Hormone therapy and venous thromboembolism among postmenopausal women. Circulation 115 (2007) 840-845
15. Grodstein F., Manson J., and Stampfer M. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health 15 (2006) 16
16. Rossouw J., Prentice R., Manson J., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297 (2007) 1465-1477
17. Salpeter S. Coronary heart disease events associated with hormone therapy in younger an dolder women. J Gen Intern Med 21 (2006) 363-366
18. Manson J., Allison M.A., Rossouw J.E., et al. Estrogen therapy and coronary artery calcification. Lancet 356 (2007) 2591-2602